Core Laboratories CLB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $524.73M+1.3% | $526.52M+0.5% | $517.5M-1.0% | $517.38M+0.7% | $517.8M+1.3% | ||
| $443K-11.4% | $359K-28.8% | $422K-16.9% | $482K-5.5% | $500K-2.5% | ||
| $10.59M+25.2% | $7.61M-23.5% | $10.1M+55.4% | $9.04M+597% | $8.46M+35,367% | ||
| $53.94M-0.9% | $56.47M-3.6% | $54.81M-7.0% | $53.69M-0.3% | $54.4M-4.1% | ||
| 10.3%-0.2pp | 10.7%-0.5pp | 10.6%-0.7pp | 10.4%-0.1pp | 10.5%-0.6pp | ||
| $10.86M-5.9% | $10.57M-14.5% | $10.59M-20.7% | $11.05M-17.5% | $11.55M-14.0% | ||
| $43.08M+0.5% | $45.9M-0.6% | $44.22M-3.0% | $42.64M+5.4% | $42.85M-1.0% | ||
| $13.51M-4.3% | $15.51M+10.5% | $11.49M-37.9% | $12.42M-22.8% | $14.12M+170% | ||
| $29.03M+3.6% | $29.67M-5.5% | $32.12M+22.6% | $29.63M+25.0% | $28.03M-25.3% | ||
| 5.5%+0.1pp | 5.6%-0.4pp | 6.2%+1.2pp | 5.7%+1.1pp | 5.4%-1.9pp | ||
| $0.61+1.7% | $0.63-6.0% | $0.68+23.6% | $0.63+28.6% | $0.60-23.1% | ||
| $0.63+5.0% | $0.65-3.0% | $0.70+25.0% | $0.64+25.5% | $0.60-25.9% | ||
| 185.4M-1.1% | 186.1M-0.8% | 186.6M-0.4% | 187.2M0.0% | 187.5M+0.3% | ||
| $46.5M+11.7% | $45.43M+14.2% | $43.88M+11.5% | $41.83M+4.2% | $41.63M+16.5% | ||
| $0.63+1.6% | $0.65-5.8% | $0.7+20.7% | $0.65+25.0% | $0.62-23.5% | ||
| $0.64+8.5% | $0.660.0% | $0.69+23.2% | $0.63+26.0% | $0.59-25.3% | ||
| $443K-11.4% | $359K-28.8% | $422K-16.9% | $482K-5.5% | $500K-2.5% | ||
| $14.25M-0.5% | $14.29M-1.1% | $14.22M-2.9% | $14.25M-4.4% | $14.33M-4.9% | ||
| $10.59M+25.2% | $7.61M-23.5% | $10.1M+55.4% | $9.04M+597% | $8.46M+35,367% | ||
| $524.73M+1.3% | $526.52M+0.5% | $517.5M-1.0% | $517.38M+0.7% | $517.8M+1.3% | ||
| 187.5M-1.3% | 188.2M-1.4% | 188.9M-1.0% | 189.6M-0.5% | 190M-0.2% | ||
| $53.94M-0.9% | $56.47M-3.6% | $54.81M-7.0% | $53.69M-0.3% | $54.4M-4.1% | ||
| $68.63M-0.9% | $71.12M-3.3% | $69.46M-6.3% | $68.41M-1.2% | $69.23M-4.3% | ||
| $68.63M-0.9% | $71.12M-3.3% | $69.46M-6.3% | $68.41M-1.2% | $69.23M-4.3% | ||
| 13.1%-0.3pp | 13.5%-0.5pp | 13.4%-0.8pp | 13.2%-0.3pp | 13.4%-0.8pp | ||
| $53.94M-0.9% | $56.47M-3.6% | $54.81M-7.0% | $53.69M-0.3% | $54.4M-4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Core Laboratories's revenue?
- Core Laboratories (CLB) generated $524.7M in revenue over the trailing twelve months, up 1.3% year over year.
- Is Core Laboratories profitable?
- Core Laboratories reported $29.0M in net income over the trailing twelve months, a 5.5% net margin.
- What is Core Laboratories's earnings per share?
- Core Laboratories's diluted EPS over the trailing twelve months is $0.61.
- Where does Core Laboratories's income statement data come from?
- Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
